Original Source(s)
Related Content
FDA monthly preview: Key September decisions to watch
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
-
5 min
FDA Expands Test for Gastric and Esophageal Cancers
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
-
2 min
Autism Spectrum Disorder Linked to Distinct Urine Metabolite Pattern
Researchers proposed a new autism spectrum disorder phenotype characterized by elevated urinary microbially derived metabolites.
July 14, 2026
-
5 min